Fourteen-Day CHOP Supported with Granulocyte Colony-Stimulating Factor in Patients with Aggressive Non-Hodgkin's Lymphoma: Results of a Phase II Study-Reference-Cited by-同舟云学术

Fourteen-Day CHOP Supported with Granulocyte Colony-Stimulating Factor in Patients with Aggressive Non-Hodgkin's Lymphoma: Results of a Phase II Study

Published:2003-09 Issue:2 Volume:4 Page:93-98
ISSN:1526-9655
Container-title:Clinical Lymphoma
language:en
Short-container-title:Clinical Lymphoma

Author:

Gregory Stephanie A.,Case Delvyn C.,Bosserman Linda,Litwak Debra L.,Berry William R.,Kalman Leonard A.,Belt Robert J.,Saven Alan

Publisher

Elsevier BV

Subject

Cancer Research

Reference24 articles.

1. Diffuse large-cell lymphoma;Fisher;Ann Oncol,2000

2. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma;Fisher;N Engl J Med,1993

3. Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables;Epelbaum;Cancer,1990

4. Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis;Kwak;J Clin Oncol,1990

5. Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte);Lepage;Ann Oncol,1993

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebral HSV-1 Vasculitis as a Fatal Complication of Immunosuppression in Non-Hodgkin´s Lymphoma: A Case Report and Review of the Literature;Pathogens;2020-03-05

2. Targeted treatment of CD22-positive non-Hodgkin’s lymphoma with sialic acid–modified chitosan-PLGA hybrid nanoparticles;Journal of Nanoparticle Research;2019-07

3. Clinical Significance of Alk-1 Gene Abnormalities in Diffuse Large Cell Lymphoma;Clinical Medicine Insights: Oncology;2012-01

4. A novel anti-lymphoma protein RE26 from Rozites emodensis (Berk.) Moser;Applied Microbiology and Biotechnology;2011-07-13

5. Front-line therapy for nonlocalized diffuse large B-cell lymphoma: what has been demonstrated and what is yet to be established;Future Oncology;2008-04